Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-07

Clinical Trial Update: Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation

View source ↗

Summary

Completed clinical trial evaluating the safety and effectiveness of Rhofanib (tofacitinib) for alopecia areata and its severe forms, alopecia totalis and alopec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rhofanib (Tofacitinib)

Snippet

Sponsor: NanoAlvand | Conditions: Alopecia Totalis/Universalis, Alopecia Areata(AA) | Status: COMPLETED